Jiankang Jin - Concepedia

Author

Jiankang Jin

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

J. Jin, Jiankang Jin

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center China Medical University First Hospital of China Medical University University of California, San Francisco University of Oklahoma Health Sciences Center

About

Jiankang Jin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	299
2	Engineering	1	1	24
3	Health Sciences	1	1	36
4	Natural Sciences	1	1	30
5	Biomedical Engineering	1	1	24

Jiankang Jin

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer Shumei Song, Soichiro Honjo, Jiankang Jin, Clinical Cancer Research	2015	267
A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma Shumei Song, Min Xie, Ailing W. Scott, Molecular Cancer Therapeutics	2017	186
Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression Ruiping Wang, Shumei Song, Jiang‐Jiang Qin, Cancer Cell Cancer ImmunosurveillanceStromal Cell StatesMucosal ImmunologyImmunologyGastric Adenocarcinoma Progression	2023	149
YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition Jaffer A. Ajani, Yan Xu, Longfei Huo, Gut	2020	99
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma Yan Xu, Yuan Li, Jiankang Jin, Molecular Cancer	2019	82
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer – Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer Fan Li, Yan Xu, Bovey Liu, Clinical Cancer Research	2018	71
IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis Janani Panneerselvam, Jiankang Jin, Manish Shanker, PLoS ONE	2015	67
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma Shumei Song, Qiongrong Chen, Yuan Li, Gut	2021	60
PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression Shumei Song, Zhenning Wang, Yuan Li, Molecular Cancer Research	2019	49
ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer Qiongrong Chen, Shumei Song, Shaozhong Wei, Oncotarget Ec CellsEsophageal CancerApoptosisCell DeathPathology	2015	40

Page 1